Efficacy of intravenous iron in treating iron deficiency anaemia in patients with inflammatory bowel disease. are there predictors of response?

Revista Espanola de Enfermedades Digestivas

Volumn 103, Issue 5, 2011, Pages 245-249

  Ferreiro Iglesias, Rocío ^a   de Barreiro Acosta, Manuel ^a   Seijo Ríos, Susana ^a   Lorenzo, Aurelio ^a   Domínguez Muñoz, J Enrique ^a  

^a University Hospital of Santiago de Compostela   (Spain)

Author keywords

Anaemia; Inflammatory bowel disease; Intravenous iron

Indexed keywords

ADALIMUMAB; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; AZATHIOPRINE; FERRIC HYDROXIDE SUCROSE; HEMOGLOBIN; INFLIXIMAB; MESALAZINE; PREDNISOLONE;

ADULT; AGE DISTRIBUTION; ARTICLE; BIOCHEMISTRY; CONTROLLED STUDY; CROHN DISEASE; DISEASE SEVERITY; DRUG EFFICACY; ENTERITIS; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; IRON DEFICIENCY ANEMIA; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; PROSPECTIVE STUDY; SEX DIFFERENCE; SMOKING HABIT; TREATMENT OUTCOME; ULCERATIVE COLITIS;

ANEMIA, IRON-DEFICIENCY; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; INFUSIONS, INTRAVENOUS; IRON; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 80054698203     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Oldenburg B, Koningsberger JC, Van Berge Henegouwen GP. Iron and inflammatory bowel disease. Aliment Pharmacol Ther 2001;15: 429-38.
2. Gasche C. Anemia in IBD: the overlooked villain. Inflamm Bowel Dis 2000;6:142-50; discussion 151.
3. Gisbert JP, Gomollon F. Common misconceptions in the diagnosis and management of anemia in inflammatory bowel disease. Am J Gastroenterol 2008;103:1299-307.
4. Kulnigg S, Gasche C. Systematic review: managing anaemia in Crohn's disease. Aliment Pharmacol Ther 2006;24:1507-23.
5. De la Morena F, Gisbert JP. Anemia and inflammatory bowel disease. Rev Esp Enferm Dig 2008;100:285-93.
6. Gasche C, Lomer MC, Cavill I, Weiss G. Iron, anaemia, and inflammatory bowel diseases. Gut 2004;53:1190-7.
7. Wells CW, Lewis S, Barton JR, Corbett S. Effects of changes in hemoglobin level on quality of life and cognitive function in inflammatory bowel disease patients. Inflamm Bowel Dis 2006;12:123-30.
8. Gisbert JP, Bermejo F, Pajares R, Perez-Calle JL, Rodriguez M, Al-gaba A, et al. Oral and intravenous iron treatment in inflammatory bowel disease: hematological response and quality of life improvement. Inflamm Bowel Dis 2009;15:1485-91.
9. Sandborn W. Erythropoietin for inflammatory bowel disease. Gastro-enterology 1997;112:660-1.
10. Finch CA. Erythropoiesis, erythropoietin, and iron. Blood 1982;60: 1241-6.
11. Tsiolakidou G, Koutroubakis IE. Stimulating erythropoiesis in inflammatory bowel disease associated anemia. World J Gastroenrol 2007;13:4798-806.
12. Schröder O, Mickisch O, Seidler U, de Weerth A, Dignass AU, Her-farth H, et al. Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease - a randomized, controlled, open-label, multicenter study. Am J Gatroenterol 2005;100:2503-9.
13. Erichsen K, Ulvik RJ, Grimstads T, Berstad A, Berge RK, Hausken T. Effects of ferrous sulphate and non-ionic iron-polymaltose complex on markers of oxidative tissue damage in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2005;22:831-8.
14. Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party of the 2005 Montreal World Congress of Gastroenterology. CAN J Gastroenterol 2005;19(Supl.A):5-36.
15. Freire WB. Iron-deficiency anemia: PAHO/WHO strategies to fight. Salud Publica Mex 1988;40:199-205.
16. Ganzoni AM. Intravenous iron-dextran: therapeutic and experimental possibilities. Schweiz Med Wochenschr 1970;100:301-3.
17. Wilson A, Reyes E, Ofman J. Prevalence and outcomes of anaemia in inflammatory bowel disease: a systematic review of the literature. Am J Med 2004;116:44S-49S.
18. Dyer NH, Dawson AM. Malnutrition and malabsorption in Crohn's disease with reference to the effect of surgery. Br J Surg 1973;60: 134-40.
19. Child JA, Brozovic B, Dyer NH, Mollin DL, Dawson AM. The diagnosis of iron deficiency in patients with Crohn's disease. Gut 1973;14:642-8.
20. Beguin Y. Soluble transferrin receptor for the evaluation of erythro-poiesis and iron status. Clin Chim Acta 2003;329:9-22.
21. Guagnozzi D, Severi C, Ialongo P, Viscido A, Patrizi F, Testino G, et al. Ferritin as a simple indicator of iron deficiency in anemic inflammatory bowel disease patients. Inflamm Bowel Dis 2006;12:150-1.
22. Goddard AF, McIntyre AS, Scott BB. Guidelines for the management of iron deficiency anemia. Bristish Society of Gastroenterology. Gut 2000;46:4;1-5.
23. Silverstein SB, Rodgers GM. Parenteral iron therapy options. Am J Hematol 2004;76:74-8.
24. Oreiro MB. Anemia ferropenica. Tratamiento. Rev Esp Enferm Dig 2009;101:70.
25. Gasche C, Waldhoer T, Feichtenschlager T, Male C, Mayer A, Mit-termaier C, et al. Prediction of response to iron sucrose in inflammatory bowel disease-associated anemia. Am J Gastroenterol 2001;96: 2382-7.
26. Erichsen K, Ulvik RJ, Nysaeter G, Johansen J, Ostborg J, Berstad A, et al. Oral ferrous fumarate or intravenous iron sucrose for patient with inflammatory bowel disease. Scand J Gastroenterol 2005;40: 1058-65.
27. Mamula P, Piccoli DA, Peck SN, Markowitz JE, Baldassano RN. Total dose intravenous infusion of iron dextran for iron-deficiency anemia in children with inflammatory bowel disease. J Pediatric Gastro-enterol Nutr 2002;34:286-90.
28. Kulnigg S, Stoinov S, Simanenkov V, Dudar LV, Karnafel W, Garcia LC. A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERIN-JECT) randomized, controlled trial. Am J Gastroenterol 2008;103: 1182-92.